Mares-Quinones M, Galan-Vasquez E, Perez-Rueda E, Perez-Ishiwara D, Medel-Flores M, Gomez-Garcia M
Sci Rep. 2024; 14(1):12350.
PMID: 38811600
PMC: 11137066.
DOI: 10.1038/s41598-024-61908-4.
Gorbokon N, Timm P, Dum D, Menz A, Buscheck F, Volkel C
Diagnostics (Basel). 2023; 13(6).
PMID: 36980510
PMC: 10047670.
DOI: 10.3390/diagnostics13061202.
Kusumastuti R, Kumagai Y, Ishihara S, Enomoto A, Murakami T, Yasuda M
FEBS Open Bio. 2022; 12(10):1797-1813.
PMID: 35945910
PMC: 9527592.
DOI: 10.1002/2211-5463.13468.
Jacqueline C, Finn O
Semin Immunol. 2020; 47:101394.
PMID: 32273212
PMC: 7164634.
DOI: 10.1016/j.smim.2020.101394.
Nguyen H, Dao M
Breast Cancer (Dove Med Press). 2019; 11:143-150.
PMID: 30936743
PMC: 6429994.
DOI: 10.2147/BCTT.S193777.
Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5.
Zombori T, Cserni G
Pathol Oncol Res. 2017; 24(2):259-267.
PMID: 28470571
DOI: 10.1007/s12253-017-0246-y.
Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.
Tiriveedhi V, Tucker N, Herndon J, Li L, Sturmoski M, Ellis M
Clin Cancer Res. 2014; 20(23):5964-75.
PMID: 25451106
PMC: 4322416.
DOI: 10.1158/1078-0432.CCR-14-0059.
Human mammaglobin in breast cancer: a brief review of its clinical utility.
Al Joudi F
Indian J Med Res. 2014; 139(5):675-85.
PMID: 25027076
PMC: 4140031.
Immunohistochemical characterization of neoplastic cells of breast origin.
Noriega M, Paesani F, Perazzo F, Lago N, Krupitzki H, Nieto S
Diagn Pathol. 2012; 7:73.
PMID: 22726568
PMC: 3468373.
DOI: 10.1186/1746-1596-7-73.
Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin.
Lewis G, Subhawong A, Nassar H, Vang R, Illei P, Park B
Am J Clin Pathol. 2011; 135(4):587-91.
PMID: 21411781
PMC: 4352296.
DOI: 10.1309/AJCPMFR6OA8ICHNH.
Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers.
Basha H, Tiriveedhi V, Fleming T, Gillanders W, Mohanakumar T
Breast Cancer Res Treat. 2010; 127(1):81-9.
PMID: 20544273
PMC: 3926801.
DOI: 10.1007/s10549-010-0975-z.
Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.
Li L, Herndon J, Truscott S, Hansen T, Fleming T, Goedegebuure P
Vaccine. 2010; 28(8):1911-8.
PMID: 20188246
PMC: 2830906.
DOI: 10.1016/j.vaccine.2009.10.096.
Gene expression of circulating tumour cells in breast cancer patients.
Bolke E, Orth K, Gerber P, Lammering G, Mota R, Peiper M
Eur J Med Res. 2009; 14(10):426-32.
PMID: 19748849
PMC: 3352225.
DOI: 10.1186/2047-783x-14-10-426.
Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
Zafrakas M, Petschke B, Donner A, Fritzsche F, Kristiansen G, Knuchel R
BMC Cancer. 2006; 6:88.
PMID: 16603086
PMC: 1513245.
DOI: 10.1186/1471-2407-6-88.
Codon optimization of bacterial luciferase (lux) for expression in mammalian cells.
Patterson S, Dionisi H, Gupta R, Sayler G
J Ind Microbiol Biotechnol. 2005; 32(3):115-23.
PMID: 15761767
DOI: 10.1007/s10295-005-0211-8.
Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.
Zehentner B, Persing D, Deme A, Toure P, Hawes S, Brooks L
Clin Chem. 2004; 50(11):2069-76.
PMID: 15375015
PMC: 1482781.
DOI: 10.1373/clinchem.2004.038687.
Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data.
Koga T, Horio Y, Mitsudomi T, Takahashi T, Yatabe Y
J Mol Diagn. 2004; 6(2):90-5.
PMID: 15096563
PMC: 1867472.
DOI: 10.1016/S1525-1578(10)60495-3.
Relationship between mammaglobin expression and estrogen receptor status in breast tumors.
Guan X, Hamedani M, Adeyinka A, Walker C, Kemp A, Murphy L
Endocrine. 2003; 21(3):245-50.
PMID: 14515009
DOI: 10.1385/ENDO:21:3:245.
Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype.
Nunez-Villar M, Martinez-Arribas F, Pollan M, Lucas A, Sanchez J, Tejerina A
Breast Cancer Res. 2003; 5(3):R65-70.
PMID: 12793902
PMC: 165002.
DOI: 10.1186/bcr587.
Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.
Zehentner B, Dillon D, Jiang Y, Xu J, Bennington A, Molesh D
Clin Chem. 2002; 48(8):1225-31.
PMID: 12142378
PMC: 1482782.